title: Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.
authors.affiliation: Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK. mboyce@hmrlondon.com.
authors.forename: Malcolm
authors.identifier: 0000-0001-8807-612X
authors.initials: M
authors.lastname: Boyce
authors.affiliation: Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.
authors.forename: Frans
authors.initials: F
authors.lastname: van den Berg
authors.affiliation: Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.
authors.forename: Toni
authors.initials: T
authors.lastname: Mitchell
authors.affiliation: Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.
authors.forename: Kate
authors.initials: K
authors.lastname: Darwin
authors.affiliation: Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, UK.
authors.forename: Steve
authors.initials: S
authors.lastname: Warrington
mesh_terms: D001570:Benzodiazepinones; D064098:Esomeprazole; D005744:Gastric Acid; D005755:Gastrins; D006801:Humans; D043887:Receptor, Cholecystokinin B
chemical_list: D001570:Benzodiazepinones; D005755:Gastrins; D043887:Receptor, Cholecystokinin B; D064098:Esomeprazole